Paraoxonase 1 gene polymorphisms influence clinical features of open-angle glaucoma

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 244, Issue 8, 2006, Pages 984-990

  Inagaki, Yoko ^a   Mashima, Yukihiko ^a   Funayama, Tomoyo ^a   Ohtake, Yuichiro ^a   Fuse, Nobuo ^b   Yasuda, Noriko ^c   Fukuchi, Takeo ^d   Murakami, Akira ^e   Hotta, Yoshihiro ^f  

^a KEIO UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKYO METROPOLITAN POLICE HOSPITAL   (Japan)

^d NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^e JUNTENDO UNIVERSITY   (Japan)

^f HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Genetic polymorphisms; Intraocular pressure; Normal tension glaucoma; Open angle glaucoma; Paraoxonase 1

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; ARYLDIALKYLPHOSPHATASE 2; HIGH DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; GENE FREQUENCY; GENE LOCATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; INTRAOCULAR PRESSURE; JAPAN; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN MODIFICATION; SINGLE NUCLEOTIDE POLYMORPHISM; VISUAL FIELD;

ADULT; AGED; ARYLDIALKYLPHOSPHATASE; FEMALE; GENE FREQUENCY; GENOTYPE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 33746877066     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-005-0200-7     Document Type: Article

References (38)

1. Aviram M, Billecke S, Sorenson R, Bisgaier C, Newton R, Rosenblat M, Erogul J, Hsu C, Dunlop C, La Du B (1998) Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: Selective action of human paraoxonase allozymes Q and R. Arterioscler Thromb Vasc Biol 18:1617-1624
2. Brezin AP, Bechetoille A, Hamard P, Valtot F, Berkani M, Belmouden A, Adam MF, Dupont de Dinechin S, Bach JF, Garchon HJ (1997) Genetic heterogeneity of primary open angle glaucoma and ocular hypertension: linkage to GLC1A associated with an increased risk of severe glaucomatous optic neuropathy. J Med Genet 34:546-552
3. Cao H, Girard-Globa A, Berthezene F, Moulin P(1999) Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q->R genetic polymorphism. J Lipid Res 40:133-139
4. Chang IL, Elner G, Yue YJ, Cornicelli A, Kawa JE, Elner VM (1991) Expression of modified low-density lipoprotein receptors by trabecular meshwork cells. Curr Eye Res 10:1101-1112
5. Copin B, Brezin AP, Valtot F, Dascotte JC, Bechetoille A, Garchon HJ (2002) Apolipoprotein E-promoter single-nucleotide polymorphisms affect the phenotype of primary open-angle glaucoma and demonstrate interaction with the myocilin gene. Am J Hum Genet 70:1575-1581
6. Deakin S, Leviev I, Guernier S, James RW (2003) Simvastatin modulates expression of the PON1 gene and increases serum paraoxonase: A role for sterol regulatory element-binding protein-2. Arterioscler Thromb Vasc Biol 23:2083-2089
7. Dielemans I, Vingerling JR, Wolfs RC, Hohman A, Grobbee DE, de Jong PT (1994) The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam study. Ophthalmology 101:1851-1855
8. Flammer J, Haefliger IO, Orgul S, Resink T(1999)Vascular dysregulation: a principal risk factor for glaucomatous damage? J Glaucoma 8:212-219
9. Fuchsjager-Mayrl G, Wally B, Georgopoulos M, Rainer G, Kircher K, Buehl W, Amoako-Mensah T, Eichler HG, Vass C, Schmetterer L (2004) Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci 45:834-839
10. Funayama T, Ishikawa K, Ohtake Y, Tanino T, Kurosaka D, Kimura I, Suzuki K, Ideta H, Nakamoto K, Yasuda N, Fujimaki T, Murakami A, Asaoka R, Hotta Y, Tanihara H, Kanamoto T, Mishima H, Fukuchi T, Abe H, Iwata T, Shimada N, Kudoh J, Shimizu N, Mashima Y(2004) Variants in optineurin gene and their association with tumor necrosis factor-α polymorphisms in Japanese patients with glaucoma. Invest Ophthalmol Vis Sci 45:4359-4367
11. Garin MC, James RW, Dussoix P, Blanche H, Passa P, Froguel P, Ruiz J (1997) Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest 99:62-66
12. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M; Early Manifest Glaucoma Trial Group (2002) Reduction of intraocular pressure and glaucoma progression: Results from the early manifest glaucoma trial. Arch Ophthalmol 120:1268-1279
13. Henry E, Newby DE, Webb DJ, O'Brien C (1999) Peripheral endothelial dysfunction in normal pressure glaucoma. Invest Ophthalmol Vis Sci 40:1710-1714
14. Imai Y, Morita H, Kurihara H, Sugiyama T, Kato N, Ebihara A, Hamada C, Kurihara Y, Shindo T, Oh-hashi Y, Yazaki Y (2000) Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases. Atherosclerosis 149:435-442
15. Ishikawa K, Funayama T, Ohtake Y, Tanino T, Kurosaka D, Suzuki K, Ideta H, Fujimaki T, Tanihara H, Asaoka R, Naoi N, Yasuda N, Iwata T, Mashima Y (2004) Novel MYOC gene mutation, Phe369Leu, in Japanese patients with primary open-angle glaucoma detected by denaturing high-performance liquid chromatography. J Glaucoma 13:466-471
16. Ito T, Yasue H, Yoshimura M, Nakamura S, Nakayama M, Shimasaki Y, Harada E, Mizuno Y, Kawano H, Ogawa H (2002) Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm. Hum Genet 110:89-94
17. Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S, Kuwayama Y, Mishima H, Shimizu H, Tomita G, Inoue Y, Kitazawa Y, Tajimi Study Group, Japan Glaucoma Society. (2004) The prevalence of primary open-angle glaucoma in Japanese: The Tajimi Study. Ophthalmology 111:1641-1648
18. Kakafika AI, Xenofontos S, Tsimihodimos V, Tambaki AP, Lourida ES, Kalaitzidis R, Cariolou MA, Elisaf M, Tselepis AD (2003) The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity. J Lipid Res 44:1919-1926
19. Klein BE, Klein R, Sponsel WE, Franke T, Cantor LB, Martone J, Menage MJ (1992) Prevalence of glaucoma. The Beaver Dam eye study. Ophthalmology 99:1499-1504
20. Lyamichev V, Mast AL, Hall JG, Prudent JR, Kaiser MW, Takova T, Kwiatkowski RW, Sander TJ, de Arruda M, Arco DA, Neri BP, Brow MA (1999) Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes. Nat Biotechnol 17:292-296
21. Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN (1998) Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett 423:57-60
22. Mackness MI, Arrol S, Durrington PN (1991) Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett 286:152-154
23. Mackness MI, Arrol S, Abbott C, Durrington PN (1993) Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 104:129-135
24. Mackness MI, Durrington PN, Mackness B (2000) How high-density lipoprotein protects against the effects of lipid peroxidation. Curr Opin Lipidol 11:383-388
25. Martinelli N, Girelli D, Olivieri O, Stranieri C, Trabetti E, Pizzolo F, Friso S, Tenuti I, Cheng S, Grow MA, Pingnatti PF, Corrocher R (2004) Interaction between smoking and PON2 Ser311Cys polymorphism as a determinant of the risk of myocardial infarction. Eur J Clin Invest 34:14-20
26. McGwin G Jr, McNeal S, Owsley C, Girkin C, Epstein D, Lee PP (2004) Statins and other cholesterol-lowering medications and the presence of glaucoma. Arch Ophthalmol 122:822-826
27. Oliveira SA, Mansur AP, Ribeiro CC, Ramires JA, Annichino-Bizzacchi JM (2004) PON1 M/L55 mutation protects high-risk patients against coronary artery disease. Int J Cardiol 94:73-77
28. Primo-Parmo SL, Sorenson RC, Teiber J, La Du BN (1996) The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 33:498-507
29. Ruiz J, Blanche H, James RW, Garin MC,Vaisse C, Charpentier G, Cohen N, Morabia A, Passa P, Froguel P (1995) Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet 346:869-872
30. Simon BC, Cunningham LD, Cohen RA (1990) Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest 86:75-79
31. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC (1994) Family history and risk of primary open angle glaucoma. The Baltimore eye survey. Arch Ophthalmol 112:69-73
32. Ueno T, Shimazaki E, Matsumoto T, Watanabe H, Tsunemi A,Takahashi Y, Mori M, Hamano R, Fujioka T, Soma M, Matsumoto K, Kanmatsuse K (2003) Paraoxonase1 polymorphism Leu-Met55 is associated with cerebral infarction in Japanese population. Med Sci Monit 9:CR260-264
33. Watson AD, Navab M, Hama SY, Sevanian A (1995) Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J Clin Invest 95:774-782
34. Wheeler JG, Keavney BD, Watkins H, Collins R, Danesh J (2004) Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: Meta-analysis of 43 studies. Lancet 363:689-695
35. Wilson MR (1996) Epidemiology of chronic open-angle glaucoma. In: Ritch R, Shields MB, Krupin T (eds) The glaucomas, vol II: Clinical science. Mosby, St. Louis, pp753-768
36. Yablonski ME (1979) An analysis of the "vascular hypothesis" concerning optic disc pathology in glaucoma. Ann Ophthalmol 11:67-69
37. Yamada Y, Ichihara S, Izawa H, Tanaka M, Yokota M (2001) Association of a G994->T (Val279->Phe) polymorphism of the plasma platelet-activating factor acetylhydrolase gene with myocardial damage in Japanese patients with nonfamilial hypertrophic cardiomyopathy. J Hum Genet 46:436-441
38. Zintzaras E, Hadjigeorgiou GM (2004) Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: A meta-analysis. J Hum Genet 49:474-481